Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 231 - 240 of 245 for gsk. (0.07 seconds)

CBT 200 Tumbles 40 Points. More details...
Second Time In Two Months. More details...
Anti-Psychotics A Big Winner. More details...
CBT 200 Drops 39 Points. More details...
CBT 200 Adds On 32 Points. More details...
CBT 200 Drops 40 Points. More details...
CBT 200 Rises 16 Points. More details...
CBT 200 Little Changed With 12 Point Rise. More details...
CBT 200 Drops 16 Points. More details...
CBT 200 Gives Up Gains. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital